Thomas Broggini

Dr. Thomas Broggini

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MFMatthäus Felsenstein
Matthäus Felsenstein
ABAnne Blank
Anne Blank
ABAlexander Bungert
Alexander Bungert
AMAnnett Mueller
Annett Mueller
AGAdnan Ghori
Adnan Ghori
SBSusan Brandenburg
Susan Brandenburg
Glioblastoma multiforme (GBM) shows a high influx of tumor-associated macrophages (TAMs). The CCR2/CCL2 pathway is considered a relevant signal for the recruitment of TAMs and has been suggested as a therapeutic target in malignant gliomas. We found that TAMs of human GBM specimens and of a syngeneic glioma model express CCR2 to varying extents. Using a Ccr2-deficient strain for glioma inoculation revealed a 30% reduction of TAMs intratumorally. This diminished immune cell infiltration occurred with augmented tumor volumes likely based on increased cell proliferation. Remaining TAMs in Ccr2-/- mice showed comparable surface marker expression patterns in comparison to wildtype mice, but expression levels of inflammatory transcription factors (Stat3, Irf7, Cox2) and cytokines (Ifnβ, Il1β, Il12α) were considerably affected. Furthermore, we demonstrated an impact on blood vessel integrity, while vascularization of tumors appeared similar between mouse strains. The higher stability and attenuated leakiness of the tumor vasculature imply improved sustenance of glioma tissue in Ccr2-/- mice. Additionally, despite TAMs residing in the perivascular niche in Ccr2-/- mice, their pro-angiogenic activity was reduced by the downregulation of Vegf. In conclusion, lacking CCR2 solely on tumor microenvironmental cells leads to enhanced tumor progression, whereby high numbers of TAMs infiltrate gliomas independently of the CCR2/CCL2 signal.

Verified
Journal Article
Open access
PDF file
APAndras Piffko
Andras Piffko
CUChristian Uhl
Christian Uhl
Peter VajkoczyPeter Vajkoczy
Peter Vajkoczy
MCMarcus Czabanka
Marcus Czabanka
TBThomas Broggini
Thomas Broggini
EphrinB2–EphB4 signaling is critical during embryogenesis for cardiovascular formation and neuronal guidance. Intriguingly, critical expression patterns have been discovered in cancer pathologies over the last two decades. Multiple connections to tumor migration, growth, angiogenesis, apoptosis, and metastasis have been identified in vitro and in vivo. However, the molecular signaling pathways are manifold and signaling of the EphB4 receptor or the ephrinB2 ligand is cancer type specific. Here we explore the impact of these signaling pathways in neurooncological disease, including glioma, brain metastasis, and spinal bone metastasis. We identify potential downstream pathways that mediate cancer suppression or progression and seek to understand it´s role in antiangiogenic therapy resistance in glioma. Despite the Janus-faced functions of ephrinB2–EphB4 signaling in cancer Eph signaling remains a promising clinical target.

Verified
Journal Article
Open access
PDF file
MGMaximilian Geissler
Maximilian Geissler
WJWeiyi Jia
Weiyi Jia
EKEmine Nisanur Kiraz
Emine Nisanur Kiraz
IKIda Kulacz
Ida Kulacz
XLXiao Liu
Xiao Liu
TBThomas Broggini
Thomas Broggini
Metastasis, particularly brain metastasis, continues to puzzle researchers to this day, and exploring its molecular basis promises to break ground in developing new strategies for combatting this deadly cancer. In recent years, the research focus has shifted toward the earliest steps in the formation of metastasis. In this regard, significant progress has been achieved in understanding how the primary tumor affects distant organ sites before the arrival of tumor cells. The term pre-metastatic niche was introduced for this concept and encompasses all influences on sites of future metastases, ranging from immunological modulation and ECM remodeling to the softening of the blood–brain barrier. The mechanisms governing the spread of metastasis to the brain remain elusive. However, we begin to understand these processes by looking at the earliest steps in the formation of metastasis. This review aims to present recent findings on the brain pre-metastatic niche and to discuss existing and emerging methods to further explore the field. We begin by giving an overview of the pre-metastatic and metastatic niches in general before focusing on their manifestations in the brain. To conclude, we reflect on the methods usually employed in this field of research and discuss novel approaches in imaging and sequencing.

28 September 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
TBThomas Broggini
Thomas Broggini
APAndras Piffko
Andras Piffko
CHChristian J. Hoffmann
Christian J. Hoffmann
AGAdnan Ghori
Adnan Ghori
CHChristoph Harms
Christoph Harms
MCMarcus Czabanka
Marcus Czabanka

29 December 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KLKathrin Laue
Kathrin Laue
SPSabina Pozzi
Sabina Pozzi
JZJohanna Zerbib
Johanna Zerbib
RBRebecca Bertolio
Rebecca Bertolio
YEYonatan Eliezer
Yonatan Eliezer
UBUri Ben-David
Uri Ben-David

7 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TBThomas Broggini
Thomas Broggini
APAndras Piffko
Andras Piffko
CHChristian J. Hoffmann
Christian J. Hoffmann
CHChristoph Harms
Christoph Harms
Peter VajkoczyPeter Vajkoczy
Peter Vajkoczy
MCMarcus Czabanka
Marcus Czabanka
During the metastatic process tumor cells circulate in the blood stream and are carried to various organs. In order to spread to different organs tumor cell—endothelial cell interactions are crucial for extravasation mechanisms. It remains unclear if tumor cell dissemination to the spinal bone occurs by passive entrapment of circulating tumor cells or by active cellular mechanisms mediated by cell surface molecules or secreted factors. We investigated the seeding of three different tumor cell lines (melanoma, lung and prostate carcinoma) to the microvasculature of different organs. Their dissemination was compared to biologically passive microbeads. The spine and other organs were resected three hours after intraarterial injection of tumor cells or microbeads. Ex vivo homogenization and fluorescence analysis allowed quantification of tumor cells or microbeads in different organs. Interestingly, tumor cell distribution to the spinal bone was comparable to dissemination of microbeads independent of the tumor cell type (melanoma: 5.646% ± 7.614%, lung: 6.007% ± 1.785%, prostate: 3.469% ± 0.602%, 7 μm beads: 9.884% ± 7.379%, 16 μm beads: 7.23% ± 1.488%). Tumor cell seeding differed significantly between tumor cells and microbeads in all soft tissue organs. Moreover, there were significant differences between the different tumor cell lines in their dissemination behaviour to soft tissue organs only. These findings demonstrate that metastatic dissemination of tumor cells to spinal bone and other osseous organs is mediated by passive entrapment of tumor cells similar to passive plugging of microvasculature observed after intraarterial microbeads injection.